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Introduction
Cancer is known as a group of diseases with 
abnormalities in cell growth. It is one of the leading 
causes of mortality and disability globally (Oliver et al., 
1992; Ferlay et al., 2010). Statistically, about two-third 
of cancers occur in developing countries in where only 
5% of the cancer control tools are available (Sung et al., 
2005). Despite the progress in medical science and the 
development of treatments and increase in the number 
of survivors, being diagnosed with cancer is associated 
with a great fear of dying and a sense of helplessness 
among diagnosed patients (Brunelli et al., 2000; Blazeby 
et al., 2005; Gradauskas et al., 2006). According to The 
World Health Organization, by 2020, the incidence of 
cancers will increase by 50% and cancer will be the 
leading cause of death in the world by 2030 (Nia et al., 
2011). Esophageal cancer is the sixth leading cause of 
death and the eighth most common among all types of 
cancer in the world. It is in the fifth place in developing 
countries and its 5-year survival probability is about 
15-25% (Parkin et al., 2005; Hebert et al., 2006; Pennathur 
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et al., 2013). Esophageal cancer is classified into main 
histological types including squamous cell carcinoma 
and adenocarcinoma. Multiple epidemiological studies 
indicated that the incidence of esophageal squamous cell 
cancer is decreasing whereas the incidence of esophageal 
carcinoma is rapidly increasing. This type of esophageal 
cancer affects more than 45,000 people across the world 
(Zhang et al., 2012). The lack of premature symptoms 
and the presence of strong two-way laryngeal esophagus 
are reasons this disease is often diagnosed in a late and 
advanced stage (Allen et al., 1997; Patti and Owen, 
1997; Sundelöf et al., 2002). Geographic dispersion can 
play an important role in the incidence of esophageal 
cancer where the highest incidence rate is in “the Asian 
Esophageal Cancer Belt” which includes countries such 
as Turkey, Iran, Kazakhstan, northern and central parts 
of China mean men and women are equally affected in 
European countries, but in North America men are affected 
more (Pennathur et al., 2013). The highest incidence of 
esophageal cancer occurs in the age group of 50-70 years. 
Moreover, it has been indicated that men are more prone 
to get this type of cancer (Ferlay et al., 2010; Zendehdel, 
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2014). Surgery is known as a definitive treatment for 
esophageal cancer. However, surgical techniques can also 
impact the increase of survival in patients with esophageal 
cancer, Radiotherapy and chemotherapy are other major 
treatment options in patients with esophageal cancer 
(Napier et al., 2014). In Iran, approximately 51,000 new 
cases of cancer are reported annually. The most involving 
organ in both sexes is the gastrointestinal tract (38%) 
in which 6,500 cases are with esophagus (Sadjadi et 
al., 2005).In addition, gastrointestinal cancers are more 
common in the northern region of Iran (the region by the 
Caspian Sea) and the highest incidence of esophageal 
cancer in the world is reported by the Caspian Sea Cancer 
Center in 1973 (Mahboubi et al., 1973; Somi et al., 2008). 
Most Iranian studies have identified Esophageal, as well as 
gastric and breast cancer (except skin caner), as the most 
common cancers occurring in both sexes (Rajaiefard et 
al., 2011). Esophageal cancer is the third most common 
cancer in men and the second most common cancer in 
women in the East Azarbaijan province in Iran (Somi et 
al., 2008). Some of the risk factors for esophageal cancer 
are sex, race, drugs abuse, alcoholic drink consumption, 
obesity, and socioeconomic status (SES) (Vaughan et 
al., 1995; Tran et al., 2005). Among 35,000 death due to 
cancer reported in Iran, 5800 cases have had esophageal 
cancer (Sadjadi et al., 2005). Whereas, limited studies 
have been done regarding the survival of patients with 
esophageal cancer in Iran the survival analysis of patients 
with esophageal cancer is very important and appropriate 
statistical models can better introduce the important 
prognostic factors to improve patients’ survival.
Time to event are the most common types of data in 
medical problems. Lots of statistical tools are available 
to analyze this data including parametric models such as 
Weibull distribution, semi-parametric approaches such 
as Cox and quantile regression, and non-parametric tools 
such as Kaplan-Meyer estimations (Portnoy, 2003; Cox, 
2018). Semi-parametric survival models (Cox Proportional 
hazard model) require multiple important assumption 
including proportional hazard (PH) assumption which 
illustrate the effect of covariate on hazard function at a 
constant rate over time. Where the PH assumption does not 
hold, there has been misinterpretation in hazard ratio (HR) 
estimation. Despite the several advantages of Cox models, 
the difficulty in HR interpretation is identified as a major 
problem (Xue et al., 2018). However other approaches 
(parametric survival models) such as the accelerated 
failure time (AFT) model give us direct interpretation of 
covariate effects on event time, it requires homogenous 
treatment effect assumption. Therefore, the necessity of 
method that does not require the assumption of classic 
survival method (parametric and semi-parametric model) 
is needed. Since censored quantile regression (CQR) 
model provide more dynamic relationship between 
covariate and survival time and having straightforward 
interpretation than classic survival models, this approach 
can be considered as a useful tool in modeling time to 
event data (Xue et al., 2018). 
Although the prevalence of esophageal cancer in the 
East Azarbaijan province is high, few studies have been 
conducted to assess the survival rate of patients. The 
present study intends to determine the important risk 
factors on the survival of patients with esophageal cancer 
using censored quantile regression model. 
Materials and Methods
This retrospective cohort study obtained information 
on patients with gastrointestinal cancer during the years 
2009-2010 using the database of centralized registration 
of all cancer cases in Iran (Country Registration Program). 
All pathological centers in Iran are asked to report all 
of their cancer cases to the center through a computer 
program annually. The data from this study was collected 
from 127 cases of patients with esophageal cancer who 
lived in the cities of East Azarbaijan province in north east 
of Iran. The patients’ information were extracted from their 
hospital and health center records.The patients referred 
to health centers and hospitals in this province were 
followed up for 5 years till 2015. The beginning of the 
study was considered as the date of pathologic diagnosis 
of esophageal cancer and the event was considered death 
due to esophageal cancer. The patients that survived 
from esophageal cancer until the end of the study were 
considered as right censored. 
The current study used several available factors 
to assess the time to event among the patients. The 
utilized factors were sex (male/female), age at the time 
of diagnosis ((≤55/ ≥56 years), smoking habits (yes/no), 
education (illiterate/literate), marital status (married/ 
single), residence (province center/urban/rural), surgery 
(yes/no), chemotherapy (yes/no), radiotherapy (yes/no), 
hormone therapy (yes/no),  alcoholic drinks consumption 
(yes/no), biopsy type (Endoscopy/ others) and time 
interval between symptom-diagnosis (≤2/ ≥3 month). In 
addition, we used principal components analysis in order 
to achieve an indicator of socio-economic status (high/ 
Low level) using a check list that consisted of questions 
on household fuel consumption, residential facilities, 
personal family facilities, household appliances used by 
the family, source of household income and total monthly 
household income. Patients’ age and time interval between 
symptom-diagnosis were categorized based on their most 
critical cut-off point in the patients’ survival. 
However, there are lots of other factors related to the 
lifetime of esophageal cancer such as metastatic status, 
tumor size, the stage of disease and the certain type of 
esophageal cancer (adenocarcinoma and squamous). 
These prognostic factors were not assessed because of 
the lack of access to the medical records of patients in the 
East-Azarbayjan cancer registry center. 
Statistical analysis
Descriptive characteristics of the patients were shown 
as mean (± standard error) and frequency (percentage) for 
continuous and categorical variables, respectively. The 
mean survival time for each variable and its subgroups 
were calculated and compared using the Kaplan-Meyer 
estimator. Moreover, a log-rank test was performed 
to assess the distribution differences among variables 
subgroups. 
However  popular classical statistical tools like 
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the study. Based on Figure 1 a decreasing trend of survival 
probability is observed and the one, three, and six-month, 
and one and three-year survival probabilities are 0.95, 0.76, 
0.60, 0.43, and 0.18. The characteristics of the patients are 
shown in Table 1. The patients’ characteristics included 
the following features rural inhabitants (41.7%),high 
socioeconomic status (51.2%), male (55.1%), illiterate 
parametric and semi-parametric survival models are 
available to analyze time to event data, censored 
quantile regression (CQR) model provides flexible 
linear model with direct and easily interpretation of 
estimation compared to AFT models. Furthermore, the 
main advantage of CQR model is the ability to predict 
the distribution of time to event which Cox model does 
not contain this major capability. Clinicians and medical 
researcher can demonstrate risk of interested events over 
time by using multivariate CQR model which cannot 
measured by Kaplan-Meier Methods. In fact CQR model 
can accommodate a model of quantile function of time to 
event which measures quantile to demonstrate the level 
of survival phase (Xue et al., 2018).
In the current study, we used censored quntile 
regression to find the overall survival of the patients using 
adjusted effects of variables (Fitzenberger, 1997; Portnoy, 
2003; Wang and Wang, 2009). This model provides 
clinicians and physicians with numerous quantiles of 
survival time based on several risk factors (Fitzenberger, 
1997; Portnoy, 2003; Wang and Wang, 2009). This model 
estimates the pth quantile of survival time (Qp) as follows 
in which X’s are the covariates and factors, βp is the 
coefficient for the pth quantile.
Q(p|X)=X^’ βp
For example, Q50=a(days) means that a randomly 
selected person from the sample has a probability of 0.5 
for experiencing the event within a days. This model uses 
bootstrap resampling method to estimate the coefficients’ 
standard error. The CQR model used the significant factors 
in the log-rank test results to assess the amount of adjusted 
effects of the independent factors on the survival of the 
patients. 
The performance of CQR model was compared 
with the frequently used proportional hazards Cox 
regression model using the Chambless and Diao’s 
estimator of cumulative/dynamic AUC for right-censored 
time-to-event data (Chambless and Diao, 2006). To do 
so, the data was divided into two sets of train (70%) and 
test (30%) randomly. To find more reliable results, the 
cross-validation was repeated 500 times and the mean 
accuracy measure was presented for the models. The 
train set was utilized for model fitting and the validation 
of the results was checked by the test set. In order to 
assess the proportionality of the hazards between the 
independent variables groups, the Schoenfeld residuals 
was used. The data analysis was carried out using the 
“survival”, “quantreg” and “survAUC” in the statistical 
programing R language version 3.3.1. All statistical 
tests were 2-sided and a p-value<0.05 were considered 
statistically significant. 
Results
The mean (± standard deviation) age of the 127 
patients was 66.92 (± 11.95) years. The survival time 
ranged from 0.10 to 69.03 month and the mean and median 
survival time was 16.99 and 10.06 months respectively. A 
total of 113 individuals (89%) lost to death by the end of 
Variable n 
 (%)
Death  
(%)
113 (89)
Mean survival 
time  (month)
Mean  (SE)
Log-Rank 
test
p-value
Resident 0.152
    Province 
center
42 (33.1) 36 (85.7) 20.41 (±3.35)
    Urban area 32 (25.2) 28 (87.5) 18.34 (±3.71)
    Rural area 53 (41.7) 49 (92.5) 12.96 (±2.26)
SES 0.004
    high level 65 (51.2) 54 (83.1) 21.84 (±2.89)
    low level 62 (48.8) 59 (95.1) 11.67 (±1.77)
sex <0.001
    male 70 (55.1) 68 (97.1) 10.39 (±1.29)
    female 57 (44.9) 45 (78.9) 24.44 (±3.27)
education 0.989
    illiterate 98 (77.2) 87 (88.8) 17.14 (±2.08)
    literate 29 (22.8) 26 (89.7) 16.21 (±3.42)
Smoke 0.554
    yes 42 (33.1) 40 (95.2) 14.38 (±2.21)
    no 85 (66.9) 73 (85.9) 18.07 (±2.41)
Alcohol 0.89
    yes 2 (1.6) 2 (100) 16.91 (±14.25)
    no 125 (98.4) 111 (88.8) 16.99 (±1.82)
Surgery <0.001
    yes 72 (56.7) 59 (81.9) 22.47 (±2.79)
    no 55 (43.3) 54 (98.2) 9.49 (±1.28)
Chemotherapy 0.359
    yes 58 (45.7) 53 (91.4) 17.16 (±2.15)
    no 69 (54.3) 60 (87) 16.25 (±2.61)
Radiotherapy 0.163
    yes 46 (36.2) 41 (89.1) 18.71 (±2.65)
    no 81 (63.8) 72 (88.9) 15.72 (±2.31)
Hormone therapy 0.752
    yes 2 (1.6) 2 (100) 11.53 (±8.33)
    no 125 (98.4) 111 (88.8) 17.07 (±1.82)
Biopsy type 0.811
    Endoscopy 121 (95.3) 108 (89.3) 16.86 (±1.83)
    Others 6 (4.7) 5 (83.3) 18.16 (±8.17)
Marital status 0.458
    Married 85 (66.9) 77 (90.6) 17.09 (±2.01)
    Single 42 (33.1) 36 (85.7) 16.31 (±3.47)
time interval between symptom-diagnosis (month) 0.047
    =<2 58 (45.7) 50 (86.2) 20.12 (±2.74)
    >=3 69 (54.3) 63 (91.3) 14.21 (±2.27)
Age (year) 0.025
    =<55 21 (16.5) 16 (76.2) 26.11 (±5.16)
    >55 106 (83.5) 97 (91.5) 15.06 (±1.81)
Table 1. The Patients’ Characteristics and the Results of 
Log-Rank Test
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(77.2%), unemployed (97.6%), non-smoker (66.9%), 
non-alcoholic (98.4%), with surgery (56.7%), no 
chemotherapy (54.3%), no radiotherapy (63.8%), no 
hormone therapy (98.4%), endoscopy biopsy (95.3%), 
married (66.9%), and time interval symptom diagnosis 
more than 3 months (54.3%). The mean (± standard error) 
survival time for each subgroup of the variables is shown 
in Table 1. The log-ranks test results showed that SES, 
surgery, time interval symptom diagnosis, age, and sex 
have significantly different survival distributions in their 
subgroups (p<0.05). 
Table 2 shows the results from the performed CQR 
model. The significant variables from the unadjusted 
log-rank test were entered in the model. The impact of 
selected variables in the CQR model on the survival of 
the patients were evaluated in 5, 10, 15, 20, 25, 30, 40, 
50, 60, 70, 75, 80, 85 quantiles. To explain Table 2, we 
interpret the results for three quartiles. The conditional 
first quartile, median and the third quartile of survival 
time can be formulated as follow.
Q(0.10│SES,age)=5.56-0.81(if SES=low level)-2.96 
(if age>55)
Q(0.5|sex,surgery)=17.78+7.03(if female)-3.02 (if 
no surgery)
According to the above formulas, the 10th percentile 
of survival time for a case with a low SES status and 
older than 55 years of age is 1.79 month. That is, the 
probability of survival for a person older than 55 with low 
SES on the 1.79th month is 10 percent. The probability 
of 10% experiencing the event for cases older than 55 is 
2.96 month less. Similarly, the median survival time for 
females and males without surgery is 21.79 and 14.76 
month. In other words, the probability of survival for a 
female without surgery on the 21.79th month is 50 percent 
whereas males are expected to experience the event 7.03 
Quantiles Intercept Sex (female) SES (low level) Surgery (No) time interval between symptom 
diagnosis  (>=3)
Age  (>55)
5 4.60 (2.04) -0.08 (0.84) -0.71 (0.81) 0.42 (0.56) -0.99 (0.58) -2.66 (1.47)
10 5.56 (0.76) -0.33 (0.58) -0.81 (0.24) 0.23 (0.35) -1.09 (0.66) -2.96 (0.83)
15 5.38 (0.97) -0.45 (0.85) -0.83 (0.69) 0.21 (0.65) -0.78 (0.91) -2.31 (1.27)
20 6.32 (3.35) 0.39 (1.73) -0.95 (0.81) -0.39 (1.32) -0.96 (1.03) -2.36 (3.51)
25 9.66 (3.43) 1.56 (2.68) -1.16 (0.89) -0.95 (1.63) -1.18 (1.67) -4.84 (4.51)
30 11.03 (2.97) 4.81 (2.48) -1.89 (1.22) -2.21 (1.78) -2.15 (1.71) -4.04 (4.18)
40 15.66 (7.45) 5.71 (2.74) -1.81 (1.63) -3.02 (1.85) -3.29 (1.83) -6.56 (5.64)
50 17.78 (3.84) 7.03 (2.30) -1.95 (1.97) -4.61 (1.94) -3.01 (1.73) -6.42 (3.24)
60 21.61 (7.25) 7.41 (4.24) -4.13 (2.79) -6.21 (3.15) -4.97 (4.63) -4.41 (4.75)
70 34.83 (11.89) 9.97 (5.01) -5.03 (7.30) -5.83 (3.49) -5.12 (8.96) -9.64 (5.75)
75 34.86 (8.81) 11.66 (3.54) -7.41 (4.24) -6.29 (3.01) -5.79 (3.78) -9.16 (4.90)
80 46.10 (11.74) 12.62 (4.53) -9.86 (5.81) -9.52 (5.01) -4.92 (4.61) -7.58 (4.98)
85 52.09 (16.23) 12.61 (5.82) -9.02 (5.63) -12.03 (7.14) -7.89 (5.78) -5.79 (6.49)
Table 2. The Results of Censored Quantile Regression Assessing the Effect of Sex, Age, Surgery, SESa and Time Interval Symptom 
Diagnosis on the Survival Time Quantiles
Bold cells indicate significance
Figure 1. Plot of Probability of Surviving in Esophageal 
Cancer Patients
Variables Coefficient SE p-value HR* (95% Confidence Interval)
Sex (female) -0.63 0.204 0.001 0.533 (0.356-0.793)
SES (Low level) 0.344 0.201 0.087 1.411 (0.950-2.096)
Surgery (No) 0.486 0.21 0.021 1.627 (1.076-2.461)
time interval between symptom diagnosis (>=3) 0.409 0.198 0.038 1.506 (1.021-2.221)
Age (>55) 0.488 0.276 0.077 1.630 (0.947-2.805)
* Hazard ratio
Table 3. The Results of Cox Proportional Hazards Regression Model Assessing the Effect of Sex, Aage, Surgery, SES 
and Time Interval Symptom Diagnosis on the Survival Time 
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months earlier. In addition, 50% of survival time for a 
case without surgery is 3.02 months less than that of with 
surgery. The same interpretation can be used for any other 
quantiles. As it is shown in Table 2, most of the survival 
time quantiles are affected by sex and presence/absence 
of surgery. 
The results of Cox PH regression model is shown in 
Table 3. The Schoenfeld residuals exposed proportional 
hazards between the groups of independent variables. 
The results demonstrated that the hazard of death from 
Esophageal cancer among females is 0.533 (95% CI: 
0.356-0.793) times than males. The patients without 
surgery were 1.627 times more likely to experience death 
from Esophageal cancer. Moreover, those with a time 
interval between symptom-diagnosis more than 3 were 
1.506 times more prone to die from Esophageal cancer. 
Using the “Chambless and Diao (2006)”’s estimator of 
cumulative/dynamic AUC for right-censored time-to-event 
data, the mean accuracy of the predictions for CQR and 
Cox PH models were 0.99 and 0.74, respectively.
Discussion
The current study showed that survival time after 
positive diagnosis of esophageal cancer is significantly 
affected by sex, age, socioeconomic status, surgery, and 
time the interval between symptom and diagnosis. Almost 
90% the patients in our study died before the end of the 
study. Moreover, the mean survival time was below one 
year. It was shown that the survival probability is almost 
consistently at 30 month after the diagnosis of the cancer. 
The probability of 40% to 85% experiencing death was 
related to the presence/absence of surgery and the sex of 
the patient.
Our study showed that low a socioeconomic status 
score is responsible for lower probability of survival 
from esophageal cancer. Facilities such as chemotherapy, 
hormone therapy, surgery and other potential treatments 
might not be easily accessible to patients with low SES 
contributing to an overall lower survival rate. Louwman et 
al. studied the prevalence of life-shortening factors among 
cancer patients including esophageal cancer patients with 
low socioeconomic status. In a large population-based 
research study they demonstrated that cancer patients with 
low SES were 50% more likely to suffer from another 
serious disease. The overall adverse consequences of 
esophageal cancer combined with the likelihood of having 
another serious disease may explain the lower survival 
rates among low SES patients with cancer (Louwman et 
al., 2010). Tran et al., (2005) assessed the impact of sex, 
race, socioeconomic status, and treatment on the survival 
of esophageal cancer patients. They concluded that lower 
SES is associated with less likelihood of receiving surgery 
resulting in lower survival (Summart et al., 2017). In 
another study in Kashmir, the association between the 
risk of esophageal squamous cell carcinoma and SES also 
indicated a strong inverse relationship (Dar et al., 2013). 
The data from our study also showed that males 
are more prone to die earlier. However, there was no 
significant difference between the males and females for 
the probability of survival less than 40%. This might be 
due to the fact that men are more likely to smoke and 
use tobacco, drink alcohol, and to engage in more risky 
behaviors than women. Melhado et al. debated on the 
changing face of esophageal cancer and demonstrated 
that the disease is more common among men than women 
(Melhado et al., 2010). The impact of sex on the survival 
of patients with esophageal cancer was investigated by 
Bohanes et al. and they exposed that women have longer 
survival in both metastatic and locoregional esophageal 
cancer. They rationalized that hormonal differences and 
menopause justify the controversy of the survival rates 
among two genders (Bohanes et al., 2012). The difference 
in esophageal cancer survival between males and females 
was also discussed by Mathieu et al. These researchers 
concluded that higher estrogen levels in women may 
play as a preventative agent against the cancer. They also 
illustrated that this protective performance disappears as 
females approach their Menopause (Mathieu et al., 2012). 
The present study demonstrated that undergoing surgery 
extends the survival time of patient’s with esophageal 
cancer. This treatment has been introduced as the best 
option for the management of esophageal cancer in its 
early-stage whereas chemotherapy and radiation therapy 
are suggested for later-stages. D’Amico assessed the 
outcomes after surgery among patients with esophageal 
cancer and found slight longer survival in patients with 
chemotherapy after surgery than surgery alone (D’Amico, 
2007). The health related quality of life after surgery 
as a treatment for esophageal cancer was evaluated by 
Lagergen et al. and more than half of the patents survived 
more than 3 years with improved emotional function 
(Lagergren et al., 2007). The current research also revealed 
that patients older than 55 years as well as rural resident 
patients are more likely to have shorter survival rates. The 
same cut-off point was found by Bohanes et al., (2012). 
They found that the incidence and mortality of esophageal 
cancer increases with age in both genders and in both 
rural and urban residents. They also found a higher risk 
of mortality and cancer incidence among rural residing 
patients in comparison to those living in urban areas 
(Zeng et al., 2016). The results of our data showed that the 
probability of survival reduces as time between symptom 
and diagnosis of esophageal cancer increases. We found 
that those with a period of longer than 3 months of 
Between the presence of symptoms and diagnoses are at a 
higher risk of death. Grotenhuis et al., (2010) assessed the 
delay in diagnostic workup and treatment of esophageal 
cancer and identified that short-term outcomes such as 
morbidity and mortality rates are significantly associated 
with hospital delay while the long-term consequences 
are less related. Moreover, we used censored quantile 
regression to find the probability of survival in any desired 
quantile. Regarding the skewness of time-to-event data, 
semi-parametric approaches such as quantile regression 
models can fit the data better and result in more valid 
estimations and interpretations (Portnoy, 2003). 
This study was not without limitations. There was a 
relatively small sample size utilized. Moreover, missing 
data was frequently observed in the patients’ records in 
the hospital and health centers.
We conclude that being male, having no surgery, 
Elaheh Zarean Shahraki et al
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experiencing a longer time between symptom onset and 
diagnosis, having low socioeconomic status and being 
older in age are all significant risk factors in reducing the 
probability of survival from esophageal cancer. 
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